Logo image
Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS
Journal article   Peer reviewed

Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS

Jamie M Eskuri, Christine M Stanley, Steven A Moore and Katherine D Mathews
Journal of the peripheral nervous system, Vol.17(1), pp.132-134
03/2012
DOI: 10.1111/j.1529-8027.2012.00370.x
PMCID: PMC3572939
PMID: 22462675

View Online

Abstract

Mutations in the GARS gene cause Charcot-Marie-Tooth 2D and distal spinal muscular atrophy type V - allelic disorders characterized by predominantly distal upper extremity weakness and atrophy, typically beginning during the second decade of life. We report monozygotic twin girls with onset of weakness in infancy and a previously reported GARS mutation within the anticodon-binding domain. The severity and remarkable similarity in phenotypes of these girls and the reported case suggest that mutations within the anticodon-binding domain are more damaging to aminoacyl tRNA synthetase function than those within other domains of GARS.
Anticodon - genetics Humans Polymerase Chain Reaction Female Glycine-tRNA Ligase - genetics Infant Mutation Twins, Monozygotic Charcot-Marie-Tooth Disease - genetics

Details

Metrics

Logo image